Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study

Patients with haematological malignancies (HM) and SARS-CoV-2 infection present a higher risk of severe COVID-19 and mortality. The aim of the study was to investigate whether vaccination and monoclonal antibodies (mAbs) have modified the outcomes of HM patients with COVID-19. This is a single-centr...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, Alessandra, Cogliati Dezza, Francesco, Petrucci, Flavia, Romani, Francesco Eugenio, Morviducci, Matteo, Mirabelli, Flavio Marco, Cancelli, Francesca, Valeriani, Emanuele, Marcelli, Giulia, Pugliese, Francesco, Turriziani, Ombretta, Ricci, Paolo, Venditti, Mario, Palange, Paolo, Mastroianni, Claudio Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982764/
https://www.ncbi.nlm.nih.gov/pubmed/36867292
http://dx.doi.org/10.1007/s10238-023-01027-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982764/
https://www.ncbi.nlm.nih.gov/pubmed/36867292
http://dx.doi.org/10.1007/s10238-023-01027-y

Ejemplares similares